38.89
-2.15
(-5.24%)
At close: January 10 at 4:00:01 PM EST
36.95
-1.94
(-4.99%)
After hours: January 10 at 6:57:22 PM EST
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-1,850.19
-1,850.19
-7,024.27
-13,587.12
-7,319.30
Financing Cash Flow
810.57
810.57
2,189.69
5,196.19
26,055.60
End Cash Position
5,720.09
5,720.09
6,747.99
11,627.91
19,760.02
Issuance of Capital Stock
900.00
900.00
1,217.50
4,034.88
27,744.83
Repayment of Debt
-89.73
-89.73
-86.11
-7.16
--
Free Cash Flow
-1,850.19
-1,850.19
-7,024.27
-13,587.12
-7,319.30
9/30/2021 - 3/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TPST Tempest Therapeutics, Inc.
0.9494
-3.67%
TVGN Tevogen Bio Holdings Inc.
1.4500
+12.40%
BIVI BioVie Inc.
2.2100
-6.36%
ENSC Ensysce Biosciences, Inc.
7.49
-5.31%
SILO Silo Pharma, Inc.
1.7700
+3.51%
VRAX Virax Biolabs Group Limited
2.4200
+3.42%
CERO CERo Therapeutics Holdings, Inc.
2.9600
-20.00%
IMRX Immuneering Corporation
2.0700
+3.50%
ALLR Allarity Therapeutics, Inc.
1.0400
-2.80%
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%